Both contain insulin glargine
Like GLP-1, GIP stimulates insulin secretion from pancreatic cells in a glucose-dependent manner (124)
Mild gastrointestinal effects are among the most typical initial responses
In response, the government is focusing on health reforms and chronic disease management, driving the demand for anti-obesity medications
This phenomenon is clearly observed in the STEP 2 trial of semaglutide (2.4 mg weekly), where a cumulative 33.7% of patients with obesity and T2D reported nausea throughout the duration of the trial ( It has been hypothesized that the deleterious, nauseating effects of GLP-1R agonists and the beneficial, food-intake reducing effects are inextricably linked
"GLP-1 medications like Ozempic and Wegovy directly alter appetite signaling, gastric emptying and insulin secretion, producing large, predictable effects on weight and blood sugar," Perez explains